MedPath

Anticipated and Perceived Benefits Following Hepatitis C Treatment

Completed
Conditions
Hepatitis C
Hepatitis C, Chronic
Registration Number
NCT03000023
Lead Sponsor
University of North Carolina, Chapel Hill
Brief Summary

The study is both qualitative and quantitative, gathering patient's perceptions of HCV treatment benefits before and after HCV treatment by administering surveys and conducting in-depth qualitative patient interviews. The study seeks to understand all anticipated and actual benefits patients perceive before and after viral eradication.

Detailed Description

This study employs a mixed methods (qualitative and quantitative) pre-post study design utilizing in-depth qualitative interviews and patient reported outcome surveys. Pre-treatment surveys and interviews will be conducted before HCV therapy commences to understand all potential psychological, social, physical and medical consequences perceived to be related to HCV and the patients' anticipation (hope for) of improvements in these factors after viral eradication. Post-treatment surveys and interviews will occur 4 to 8 months after treatment ends to examine long-term treatment benefits, i.e., changes in HCV-related factors, such as symptoms, functioning, and health status.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Age 21 or older
  • English-speaking
  • Any genotype
  • Any treatment duration (e.g. 8, 12, or 24 weeks)
  • Has been written a prescription for a sofosbuvir (SOF)-containing regimen.
Exclusion Criteria
  • Currently listed for liver transplant; post-liver transplant

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Analyze changes in patient perceptions through qualitative interviews before and after HCV treatment.1 Year

To conduct a pre-post qualitative analysis that will evaluate changes in a broad range of patients' perceptions of psychological, social, and physical effects associated with HCV and viral cure collected through qualitative interviews.

Evaluate pre-post survey change in patient reported HCV symptoms and other factors.1 Year

To conduct a pre-post survey evaluation of change in patient-reported HCV symptoms, functioning, and health perceptions associated with HCV and viral cure.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of North Carolina

🇺🇸

Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath